reports
Pacira BioSciences to Participate in Fireside Chat at the Barclays 28t...
Pacira BioSciences to Participate in Fireside Chat at the Barclays 28th Annual Global Healthcare Conference BRISBANE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will participate in an analyst-led fireside chat at the Barclays 28th Annual Global Healthcare Conference at 2:30 PM ET on Wednesday, March 11, 2026 in Miami. Live audio of the event can be accessed by visiting the “Events” page of the company’s ...
Texas Capital Earns Best Bank Award for Middle Market Banking in the U...
Texas Capital Earns Best Bank Award for Middle Market Banking in the U.S. (West) Clients cite strong satisfaction with the firm’s middle market banking DALLAS, March 03, 2026 (GLOBE NEWSWIRE) -- Texas Capital announced today that it has been named as a Best Bank – Likelihood to Recommend for Middle Market Banking in the U.S. (West) by Crisil Coalition Greenwich, recognizing the firm’s approach to serving middle market companies through its client-focused, full-service banking platform. Texas Capital serves small business, middle market and corporate clients across industries and geogra...
Pacira BioSciences Presents Two Real-World Studies from Its Innovation...
Pacira BioSciences Presents Two Real-World Studies from Its Innovations in Genicular Outcomes Registry (IGOR) -- Studies highlight the clinical effectiveness of EXPAREL for total knee arthroplasty and long-term pain management with ioveraº for patients with osteoarthritis (OA) of the knee -- -- Data presented at the American Academy of Orthopedic Surgeons 2026 Annual Meeting -- BRISBANE, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of p...
Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial...
Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results — Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years — — Conference call today at 4:30 p.m. ET — BRISBANE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today reported financial results for the fourth quarter and full-year of 2025. “2025 was a year of disciplined execution for P...
- Jonathan Moreland
TCBI TEXAS CAPITAL BANCSHARES INC.
POOL POOL CORPORATION
NEU NEWMARKET CORPORATION
LXRX LEXICON PHARMACEUTICALS INC.
HUM HUMANA INC.
HTGC HERCULES CAPITAL INC.
AMH AMERICAN HOMES 4 RENT CLASS A
GGT THE GABELLI MULTIMEDIA TRUST
HLNE HAMILTON LANE INCORPORATED CLASS A
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
SONO SONOS
VERX VERTEX
WRB INC.
W.R. BERKLEY CORPORATION
Magnite Reports Fourth Quarter and Full-Year 2025 Results
Magnite Reports Fourth Quarter and Full-Year 2025 Results Total Revenue up 6% & Contribution ex-TAC(1) up 8%, or 16% Excluding Political, in Fourth Quarter Contribution ex-TAC(1) From CTV Grows 20%, or 32% Excluding Political, in Fourth Quarter Adjusted EBITDA Margin(2) Increases to 43% in Fourth Quarter Announces New $200 Million Stock Buyback Program NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Magnite (NASDAQ: MGNI), the world's largest independent sell-side advertising company, today reported its results of operations for the fourth quarter and year ended December 31, 2025. Recent...
Dorchester Minerals, L.P. Announces 2025 Results
Dorchester Minerals, L.P. Announces 2025 Results DALLAS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) announced today the Partnership’s net income for the year ended December 31, 2025 of $57,352,000 or $1.16 per common unit. A comparison of the Partnership’s consolidated results for the twelve month periods ended December 31, 2025 and 2024 are set forth below: Twelve Months Ended December 31, 2025 2024Operating Revenues$152,832,000 $161,523,000Net Income$57,352,000 $92,449,000Net Income Per Common Unit$1.16 $2.13 The Partnership’s indepen...
- Blair Levin
WBD/PSKY/NFLX Update
There has been a considerable amount of news flow about the battle over WBD, including an enhanced PSKY offer and reports that PSKY has a (not so) secret plan to quickly gain antitrust approval. In this note we address those topics as well as reassessing our view, detailed in a note last week, that PSKY will find itself in a difficult position in terms of losing talent (and customers) due to political risk and/or having to pay a premium to attract talent due to that political risk, and doing so ...
- Jonathan Moreland
PYPL PAYPAL HOLDINGS INC
HTGC HERCULES CAPITAL INC.
USAC USA COMPRESSION PARTNERS LP
TSI TCW STRATEGIC INCOME FUND INC.
AXR AMREP
BIGC BIGCOMMERCE HOLDINGS
SLQT SELECTQUOTE
RBLX INC.
QDEL ROBLOX
GF QUIDEL CORP
ASST THE NEW GERMANY FUND
NDAQ INC.
ASSET ENTITIES INC.
THE NASDAQ OMX GROUP
INC.
- Blair Levin
Does the Trump/Kennedy Center Fiasco Portend PSKY's Future?
It now appears that PSKY has a good chance of prevailing in its battle for WBD. We have previously discussed the three phases of that battle; the proxy battle, the antitrust review, and the judicial review. In this note, we discuss a fourth phase; how does the battle for WBD, including this week’s Colbert/Talarico Affair, affect PSKY’s value after the deal closes?
Dorchester Minerals, L.P. Announces Appointment of Manager to Board of...
Dorchester Minerals, L.P. Announces Appointment of Manager to Board of Managers DALLAS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ: DMLP) announced today Mr. A. Troy Sturrock has been appointed to the board of managers of the general partner of our general partner, as an independent manager and member of the advisory committee effective February 11, 2026. Mr. Sturrock’s appointment fills the vacancy created by the death of C.W. “Bill” Russell. Mr. Sturrock has over 25 years of accounting and financial reporting experience, with a focus on the ...
Mercer International Inc. Reports Fourth Quarter 2025 and Year End 202...
Mercer International Inc. Reports Fourth Quarter 2025 and Year End 2025 Results Selected Highlights Fourth quarter Operating EBITDA* was negative $20.1 million (net loss of $308.7 million) compared to negative $28.1 million (net loss of $80.8 million) in the third quarter of 2025Full year 2025 Operating EBITDA was negative $22.0 million (net loss of $497.9 million) compared to positive $243.7 million (net loss of $85.1 million) in 2024Included in net loss for the fourth quarter are total non-cash impairments of $238.7 million, primarily on long-lived assets at our Peace River mill due to t...
Pacira to Report 2025 Financial Results on Thursday February 26, 2026
Pacira to Report 2025 Financial Results on Thursday February 26, 2026 BRISBANE, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will report its fourth quarter and year ended December 31, 2025 financial results after the close of the U.S. markets on Thursday February 26, 2026. Following the release, the company will host a live conference call and webcast at 4:30 p.m. ET. For listeners who wish to participate ...
- Blair Levin
What Does the PSKY Announcement of Compliance Mean?
As part of a new bid to buy WBD, PSKY announced that it had already complied with the DOJ’s second request. Investors have been asking about how to understand this announcement, how the timing of this review compares with other DOJ investigations and what are the paths forward for the antitrust review of both PSKY and NFLX’s bid. In this note we address those questions.
Pacira Highlights New NOPAIN Act Survey Data Conducted by Voices for N...
Pacira Highlights New NOPAIN Act Survey Data Conducted by Voices for Non-Opioid Choices BRISBANE, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies, today highlighted new survey findings released by the Voices for Non-Opioid Choices (Voices) coalition following the first year of the Non-Opioids Prevent Addiction (“NOPAIN”) Act. Made up of more than 250 organizations dedicated to preventing opioid addiction before it starts, Voices is the nation’s leading nonpartisan coa...
H&R Block Rolls Out the Green Carpet for Creators with Game-Changing P...
H&R Block Rolls Out the Green Carpet for Creators with Game-Changing Platform for $250B Economy Content Creator Summit in NYC Unveils Specialized Filing Tool That Speaks Their Language, Because Filing Taxes Shouldn't Be Harder Than Going Viral KANSAS CITY, Mo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- In a move signaling its commitment to America's entrepreneurial future, H&R Block (NYSE: HRB) built a customized creator tool and is hosting an exclusive creator economy event in New York City to celebrate. H&R Block is unveiling a refreshed version of its tax filing platform now specifically des...
New York Times Advertising and Magnite Enter Strategic Collaboration f...
New York Times Advertising and Magnite Enter Strategic Collaboration for In-App Supply This collaboration gives brands access to The New York Times’s premium mobile ad inventory through Magnite’s platform, enhancing addressability and performance NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- New York Times Advertising, the award-winning advertising team within The New York Times, and Magnite (NASDAQ: MGNI), the largest independent sell-side advertising company, today announced an expanded collaboration to make Magnite’s DV+ the preferred platform for private marketplace deals for The New ...
Magnite to Participate in the Susquehanna 15th Annual Technology Confe...
Magnite to Participate in the Susquehanna 15th Annual Technology Conference NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, today announced that members of its executive team will host in-person investor meetings at the Susquehanna 15th Annual Technology Conference in New York City on Thursday, February 26, 2026. About Magnite We’re Magnite (NASDAQ: MGNI), the world’s largest independent sell-side advertising company. Publishers use our technology to monetize their content across all screens and formats including...
H&R Block Combines AI Power with Digital Enhancements and Unmatched Ta...
H&R Block Combines AI Power with Digital Enhancements and Unmatched Tax Pro Expertise to Win Tax Season 2026 CNET named H&R Block as the Best Online Tax Service for 2026, praising commitment to transparent pricing, user-friendly platform, and innovative AI Tax Assistant KANSAS CITY, Mo., Feb. 09, 2026 (GLOBE NEWSWIRE) -- This tax season H&R Block (NYSE: HRB) is delivering accuracy, expertise, and tech-forward solutions designed to reduce friction at every step and help filers confidently navigate what is expected to be one of the most complex tax seasons in years. As the One Big Beautif...
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule...
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BRISBANE, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards on February 3, 2026 to 14 new employees under Pacira’s Amended and Restated 2014 Inducement Plan (the “Inducement Plan”) as a material inducement to each employee’s entry into employment with the company. In accordance with Nasdaq Listing Rule 5635(c)(4), t...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.